Sporadic male patients with intellectual disability: Contribution of X-chromosome copy number variants

European Journal of Medical Genetics

Volumn 55, Issue 11, 2012, Pages 577-585

  Isrie, M ^a   Froyen, G ^b   Devriendt, K ^a   de Ravel, T ^a   Fryns, J P ^a   Vermeesch, J R ^a   Van Esch, H ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Comparative genome hybridization; Copy number variation; HTR2C; Intellectual disability; X chromosome

Indexed keywords

ADOLESCENT; ADULT; AGED; ALGORITHM; ARTICLE; COHORT ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; GENE FREQUENCY; GENE INACTIVATION; GENETIC ANALYSIS; GENETIC COUNSELING; HUMAN; INTELLECTUAL IMPAIRMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; TASK PERFORMANCE; X CHROMOSOME;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, X; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; GENETIC COUNSELING; GENETIC LOCI; GENOME, HUMAN; HUMANS; INFANT; INTELLECTUAL DISABILITY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84867143342     PISSN: 17697212     EISSN: 18780849     Source Type: Journal    
DOI: 10.1016/j.ejmg.2012.05.005     Document Type: Article

References (55)

1. Morey C., Avner P. Genetics and epigenetics of the X-chromosome. Annals of the New York Academy of Sciences 2010, 1214:E18-E33.
2. de Brouwer A.P.M., et al. Mutation frequencies of X-linked mental retardation genes in families from the EuroMRX consortium. Human Mutation 2007, 28:207-208.
3. Madrigal I., et al. X-chromosome tiling path array detection of copy number variants in patients with chromosome X-linked mental retardation. BMC Genomics 2007, 8:443.
4. Bauters M., Van Esch H., Marynen P., Froyen G. X chromosome array-CGH for the identification of novel X-linked mental retardation genes. European Journal of Medical Genetics 2005, 48:263-275.
5. Vissers L.E.L.M., de Vries B.A., Veltman J. Genomic microarrays in mental retardation: from copy number variation to gene, from research to diagnosis. Journal of Medical Genetics 2010, 47:289-297.
6. Froyen G., et al. Detection of genomic copy number changes in patients with idiopathic mental retardation by high-resolution X-array-CGH: important role for increased gene dosage of XLMR genes. Human Mutation 2007, 28:1034-1042.
7. Gijsbers A.C., Schoumans J., Ruivenkamp C.A. Interpretation of array comparative genome hybridization data: a major challenge. Cytogenetic and Genome Research 2011, 135:222-227.
8. Koolen D., et al. Genomic microarrays in mental retardation: a practical workflow for diagnostic applications. Human Mutation 2009, 30:283-292.
9. Menten B., et al. Emerging patterns of cryptic chromosomal imbalance in patients with idiopathic mental retardation and multiple congenital anomalies: a new series of 140 patients and review of published reports. Journal of Medical Genetics 2006, 43:625-633.
10. Van Esch H., et al. Deletion of VCX-A due to NAHR plays a major role in the occurrence of mental retardation in patients with X-linked ichthyosis. Human Molecular Genetics 2005, 14:1795-1803.
11. Van Esch H., et al. Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. American Journal of Human Genetics 2005, 77:442-453.
12. Vandewalle J., et al. Dosage-dependent severity of the phenotype in patients with mental retardation due to a recurrent copy-number gain at Xq28 mediated by an unusual recombination. American Journal of Human Genetics 2009, 85:809-822.
13. Allen R.C., Zoghbi H.Y., Moseley A.B., Rosenblatt H.M., Belmont J.W. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. American Journal of Human Genetics 1992, 51:1229-1239.
14. Helena Mangs A., Morris B.J. The human Pseudoautosomal Region (PAR): origin, function and future. Current Genomics 2007, 8:129-136.
15. Corzo D., et al. Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E: a novel neonatal phenotype similar to peroxisomal biogenesis disorders. American Journal of Human Genetics 2002, 70:1520-1531.
16. Qiao Y., et al. Autism-associated familial microdeletion of Xp11.22. Clinical Genetics 2008, 74:134-144.
17. Billuart P., et al. Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation. Nature 1998, 392:923-926.
18. Gibbons R. Alpha thalassaemia-mental retardation, X linked. Orphanet Journal of Rare Diseases 2006, 1:15.
19. Giannandrea M., et al. Mutations in the small GTPase gene RAB39B are responsible for X-linked mental retardation associated with autism, epilepsy, and macrocephaly. American Journal of Human Genetics 2010, 86:185-195.
20. Miskinyte S., et al. Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with Syndromic Moyamoya. American Journal of Human Genetics 2011, 88:718-728.
21. Witham S., Takano K., Schwartz C., Alexov E. A missense mutation in CLIC2 associated with intellectual disability is predicted by in silico modeling to affect protein stability and dynamics. Proteins 2011, 79:2444-2454.
22. Wai M.S.M., Lorke D.E., Kwong W.H., Zhang L., Yew D.T. Profiles of serotonin receptors in the developing human thalamus. Psychiatry Research 2011, 185:238-242.
23. Mochel F., Missirian C., Reynaud R., Moncla A. Normal intelligence and social interactions in a male patient despite the deletion of NLGN4X and the VCX genes. European Journal of Medical Genetics 2008, 51:68-73.
24. Laumonnier F., et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. American Journal of Human Genetics 2004, 74:552-557.
25. Lesca G., et al. Xp22.3 microdeletion including VCX-A and VCX-B1 genes in an X-linked ichthyosis family: no difference in deletion size for patients with and without mental retardation. Clinical Genetics 2005, 67:367-368.
26. Cuevas-Covarrubias S., González-Huerta L.M. Analysis of the VCX3A, VCX2 and VCX3B genes shows that VCX3A gene deletion is not sufficient to result in mental retardation in X-linked ichthyosis. The British Journal of Dermatology 2008, 158:483-486.
27. Jamain S., et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nature Genetics 2003, 34:27-29.
28. Lawson-Yuen A., Saldivar J.-S., Sommer S., Picker J. Familial deletion within NLGN4 associated with autism and Tourette syndrome. European Journal of Human Genetics 2008, 16:614-618.
29. Pavlowsky A., et al. A postsynaptic signaling pathway that may account for the cognitive defect due to IL1RAPL1 mutation. Current Biology 2010, 20:103-115.
30. Behnecke A., et al. Intragenic deletions of IL1RAPL1: report of two cases and review of the literature. American Journal of Medical Genetics Part A 2011, 155A:372-379.
31. Carrié A., et al. A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nature Genetics 1999, 23:25-31.
32. Lossi A., et al. Abnormal expression of the KLF8 (ZNF741) gene in a female patient with an X; autosome translocation t (X; 21)(p11. 2; q22. 3) and non-syndromic mental retardation. Journal of Medical Genetics 2002, 39:113-117.
33. Shoichet S., et al. Mutations in the ZNF41 gene are associated with cognitive deficits: identification of a new candidate for X-linked mental retardation. American Journal of Human Genetics 2003, 73:1341-1354.
34. Speevak M.D., Farrell S. Non-syndromic language delay in a child with disruption in the Protocadherin11X/Y gene pair. American Journal of Medical Genetics 2011, 156B:484-489.
35. Tarpey P., et al. Mutations in the DLG3 gene cause nonsyndromic X-linked mental retardation. American Journal of Human Genetics 2004, 75:318-324.
36. Bedeschi M.F., et al. Association of syndromic mental retardation with an Xq12q13.1 duplication encompassing the oligophrenin 1 gene. American Journal of Medical Genetic 2008, 146A:1718-1724.
37. El-Hattab A.W., et al. Int22h-1/int22h-2-mediated Xq28 rearrangements: intellectual disability associated with duplications and in utero male lethality with deletions. Journal of Medical Genetics 2011, 48:840-850.
38. Lugtenberg D., et al. Xq13.2q21.1 duplication encompassing the ATRX gene in a man with mental retardation, minor facial and genital anomalies, short stature and broad thorax. American Journal of Medical Genetics 2009, 149A:760-766.
39. Bérubé N.G., et al. Neurodevelopmental defects resulting from ATRX overexpression in transgenic mice. Human Molecular Genetics 2002, 11:253-261.
40. Hagens O., et al. Disruptions of the novel KIAA1202 gene are associated with X-linked mental retardation. Human Genetics 2006, 118:578-590.
41. Froyen G., et al. Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 Ubiquitin Ligase HUWE1 are associated with mental retardation. Journal of Human Genetics 2008, 82:432-443.
42. Vos Y.J., et al. Genotype-phenotype correlations in L1 syndrome: a guide for genetic counselling and mutation analysis. Journal of Medical Genetics 2010, 47:169-175.
43. Tzschach A., et al. Characterization of interstitial Xp duplications in two families by tiling path array CGH. American Journal of Medical Genetics 2008, 203:197-203.
44. Klitten L.L., Møller R.S., Ravn K., Hjalgrim H., Tommerup N. Duplication of MAOA, MAOB, and NDP in a patient with mental retardation and epilepsy. European Journal of Human Genetics 2011, 19:1-2.
45. Rio M., et al. Familial interstitial Xq27.3q28 duplication encompassing the FMR1 gene but not the MECP2 gene causes a new syndromic mental retardation condition. European Journal of Human Genetics 2010, 18:285-290.
46. Peier A.M., et al. (Over) correction of FMR1 deficiency with YAC transgenics: behavioral and physical features. Human Molecular Genetics 2000, 9:1145-1160.
47. Ji S.-P., et al. Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse. Nature Medicine 2006, 12:324-329.
48. Bauters M., et al. Nonrecurrent MECP2 duplications mediated by genomic architecture-driven DNA breaks and break-induced replication repair. Genome Research 2008, 18:847-858.
49. Vermeesch J.R., Balikova I., Schrander-Stumpel C., Fryns J.-P., Devriendt K. The causality of de novo copy number variants is overestimated. European Journal of Human Genetics 2011, 19:1-2.
50. Shaw-Smith C., et al. Microarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features. Journal of Medical Genetics 2004, 41:241-248.
51. Li F., et al. Interstitial microduplication of Xp22.31: causative of intellectual disability or benign copy number variant?. European Journal of Medical Genetics 2010, 53:93-99.
52. Liu P., et al. Copy number gain at Xp22.31 includes complex duplication rearrangements and recurrent triplications. Human Molecular Genetics 2011, 20:1975-1988.
53. Mencarelli M.A., et al. Private inherited microdeletion/microduplications: implications in clinical practice. European Journal of Medical Genetics 2008, 51:409-416.
54. Lugtenberg D., et al. Recurrent deletion of ZNF630 at Xp11.23 is not associated with mental retardation. American Journal of Medical Genetics 2010, 152A:638-645.
55. Mansouri M.R., et al. Loss of ZDHHC15 expression in a woman with a balanced translocation t(X;15)(q13.3;cen) and severe mental retardation. European Journal of Human Genetics 2005, 13:970-977.